04:53 PM EDT, 09/08/2025 (MT Newswires) -- Immix Biopharma ( IMMX ) said late Monday that it has received a strategic investment from Goose Capital and former Tanox CEO Nancy Chang, a Goose founding member.
Immix is a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other serious diseases.